BOT 1.45% 34.0¢ botanix pharmaceuticals ltd

BOT - Anything but charting, page-4063

  1. 592 Posts.
    lightbulb Created with Sketch. 96
    I might be stating the obvious, but if the BOT team has a copy of the FDA mid-cycle review letter outlining the scheduled points to be discussed during the phone call to take place, then I’d say there’s a pretty good chance BOT management currently have a strong indication of how positive the mid-cycle review will be.

    I’m wondering if the tweet from BOT today is a sign that the mid-cycle review will be positive, or why draw attention to a mid-cycle review expected to be negative?

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.